A detailed history of Newfound Research LLC transactions in Amgen Inc stock. As of the latest transaction made, Newfound Research LLC holds 187 shares of AMGN stock, worth $49,005. This represents 0.1% of its overall portfolio holdings.

Number of Shares
187
Previous 385 51.43%
Holding current value
$49,005
Previous $94,000 55.32%
% of portfolio
0.1%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $44,443 - $50,123
-198 Reduced 51.43%
187 $42,000
Q2 2022

Jul 15, 2022

BUY
$230.71 - $256.74 $16,380 - $18,228
71 Added 22.61%
385 $94,000
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $68,850 - $76,166
314 New
314 $76,000
Q1 2021

Apr 28, 2021

SELL
$221.91 - $258.6 $49,264 - $57,409
-222 Closed
0 $0
Q4 2020

Jan 22, 2021

BUY
$216.38 - $257.67 $48,036 - $57,202
222 New
222 $51,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Newfound Research LLC Portfolio

Follow Newfound Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newfound Research LLC with notifications on news.